Friday, 20 May 2022 11:54

Anticoagulation news items. Week commencing 16th May 2022

Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study

The Lancet Infectious Diseases
Study (n=909 473; 32 329 hospitalised) found occurrence of venous thromboembolism in patients with COVID-19 was associated with increased mortality (adjusted HRs 4.42 for not hospitalised and 1.63 for hospitalised), as was occurrence of arterial thromboembolism (3.16 and 1.93).

 

Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial

European Heart Journal
RCT (n=1500) found that after transcatheter aortic valve implantation, apixaban was not superior to standard of care (a vitamin K antagonist or antiplatelet), irrespective of an indication for oral anticoagulation (primary efficacy endpoint HR 0.92; 95% CI 0.73–1.16).

 

 

The above records have been identified by UKMi and feature in the NICE Medicines Awareness Service. Further details on this service can be found at:

http://www.evidence.nhs.uk/about-evidence-services/content-and-sources/medicines-information/new-medicines-awareness-services